[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335587-105":59,"doc-detail-335587-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","single-cell-dissection-reveals-immunosuppressive-f13a1-macrophage-as-a-hallmark-for-multiple-primary-lung-cancers","Single-cell dissection reveals immunosuppressive F13A1+ macrophage as a hallmark for multiple primary lung cancers","","Multiple primary lung cancers (MPLCs) are increasingly prevalent, yet the molecular programs that drive MPLC development and distinguish it from solitary primary lung cancers (SPLCs) remain unclear. Comparative single-cell RNA sequencing was performed on tumor and adjacent para-tumor tissues to map immunological landscapes. Multiplex immunofluorescence staining and independent validation datasets were used to confirm findings. MPLCs and SPLCs share broad genetic, transcriptomic, and immune similarities, while MPLCs show enrichment of an immunosuppressive F13A1+ macrophage subtype. This subtype upregulates M2 macrophage markers and enhances SPP1-CD44/CCL13-ACKR1 interactions, promoting tumor immune evasion and progression.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-cell-dissection-reveals-immunosuppressive-f13a1-macrophage-as-a-hallmark-for-multiple-primary-lung-cancers/335587/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-cell-dissection-reveals-immunosuppressive-f13a1-macrophage-as-a-hallmark-for-multiple-primary-lung-cancers/335587.png","ImageObject",300,407,{"name":92,"@type":93},"Seraphina","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-25","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main aim of this study?","Question",{"text":112,"@type":113},"To identify molecular mechanisms driving multiple primary lung cancers (MPLCs) and distinguish them from solitary primary lung cancers (SPLCs), using single-cell analysis.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were immune landscapes compared between MPLC and SPLC patients?",{"text":117,"@type":113},"The study used comparative single-cell RNA sequencing on tumor and adjacent para-tumor tissues, supported by multiplex immunofluorescence staining and independent validation datasets.",{"name":119,"@type":110,"acceptedAnswer":120},"What cellular hallmark was specifically enriched in MPLCs?",{"text":121,"@type":113},"An immunosuppressive F13A1+ macrophage subtype (Mϕ) was preferentially enriched in MPLCs and linked to immune evasion and tumor progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},335587,1790149711,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":4},962075114101,"https://ap-avatar.wpscdn.com/avatar/e000253a75eb197efd?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780044092746381165","DOI: 10.1002/ctm2.70091  \nRESEARCH ARTICLE  \nSingle-cell dissection reveals immunosuppressive F13A1+ macrophage as a hallmark for multiple primary lung cancers  \nChenglin Yang1 Youjun Deng1  \nJiahao Qu1,2 Yiran Meng3  \n Jingting Wu1  Liuqing Zheng3  \nSonghua Cai1  Wenyi Liu1   Lishen Zhang3  Li Wang3  \nXiaotong Guo1  \n1National Cancer Center/National Clinical Research Center for  \nCancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China  \n2 Southern University of Science and Technology, Shenzhen City, Guangdong Province, China  \n3 Department of R&D, Hangzhou Repugene Technology Co., Ltd., Hangzhou, China  \nCorrespondence  \nXiaotong Guo, National Cancer Cen  \nter/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China. [Email:](Email: gxt7890@163.com)[ gxt7890@163.com](Email: gxt7890@163.com)  \nGraphical Abstract  \n1. Comparative single-cell RNA sequencing (scRNA-seq) analysis reveals significant similarities in genetic, transcriptomic and immune profiles between multiple primary lung cancers (MPLCs) and solitary primary lung cancers (SPLCs) .  \n2. Identification of a unique F13A1+ macrophage subtype, preferentially enriched in MPLCs, linked to immune evasion and tumour progression.  \n3. SPP1-CD44/CCL13-ACKR1 interactions are crucial inMPLC tumour microenvironment, indicating potential targets for therapeutic intervention.  \nClin. Transl. Med. 2024;14:e70091 .  \n[https://doi.org/10.1002/ctm2.70091](https://doi.org/10.1002/ctm2.70091)  \n[wileyonlinelibrary.com/journal/ctm2](wileyonlinelibrary.com/journal/ctm2)  \nDOI: 10.1002/ctm2.70091  \nRESEARCH ARTICLE  \nSingle-cell dissection reveals immunosuppressive F13A1+ macrophage as a hallmark for multiple primary lung cancers  \nChenglin Yang1 Youjun Deng1  \nJiahao Qu1,2 Yiran Meng3  \n Jingting Wu1  Liuqing Zheng3  \nSonghua Cai1  Wenyi Liu1   Lishen Zhang3  Li Wang3  \nXiaotong Guo1  \n1National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, China  \n2 Southern University of Science and Technology, Shenzhen City, Guangdong Province, China  \n3 Department of R&D, Hangzhou Repugene Technology Co., Ltd., Hangzhou, China  \nCorrespondence  \nXiaotong Guo, National Cancer  \nCenter/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, 518116, China. [Email:](Email: gxt7890@163.com)[ gxt7890@163.com](Email: gxt7890@163.com)  \nFunding information  \nNational Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shenzhen, Grant/Award Number: SZ2020ZD01; SanMing Project of Medicine in Shenzhen, Grant/Award Number:  \nSZSM202211011; Shenzhen High-level Hospital Construction Fund; Shenzhen Key Medical Discipline Construction Fund, Grant/Award Number: SZXK075; Medical Scientific Research Foundation of Guangdong Province, China,  \nGrant/Award Number: A2022204  \nAbstract  \nBackground: The increasing prevalence of multiple primarylung cancers (MPLCs) presents challenges to current diagnostic and clinicalmanagement approaches. However, the molecular mechanisms driving MPLCdevelopment and distinguishing it from solitary primary lung cancers (SPLCs)remain largely unexplored.  \nMethods: We performed a comparative single-cell RNAsequencing (scRNAseq) analysis on tumour and adjacent para-tumour tissues fromMPLC and SPLC patients to comparatively evaluate their immunological landscapes.Additionally, multiplex immunofluorescence (mIF) staining and independentvalidation datasets were used to confirm findings.  \nResults: MPLCs and SPLCs share significant similarities in genetic, transcrip","cbCaioeGOJMFHc6P","https://ap.wps.com/l/cbCaioeGOJMFHc6P","pdf",12735110,26,"English","# Key points\n## Main findings\n# Introduction\n## Problem context\n# Methods and validation\n## scRNA-seq and mIF","[{\"question\":\"What was the main aim of this study?\",\"answer\":\"To identify molecular mechanisms driving multiple primary lung cancers (MPLCs) and distinguish them from solitary primary lung cancers (SPLCs), using single-cell analysis.\"},{\"question\":\"How were immune landscapes compared between MPLC and SPLC patients?\",\"answer\":\"The study used comparative single-cell RNA sequencing on tumor and adjacent para-tumor tissues, supported by multiplex immunofluorescence staining and independent validation datasets.\"},{\"question\":\"What cellular hallmark was specifically enriched in MPLCs?\",\"answer\":\"An immunosuppressive F13A1+ macrophage subtype (Mϕ) was preferentially enriched in MPLCs and linked to immune evasion and tumor progression.\"}]","Single-cell dissection reveals immunosuppressive F13A1+ macrophage as a hallmark for multiple primary lung cancers | PDF",1790011541,66]